Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children

about

Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.

P2860

Q52727145-6BAB4354-F862-424D-81A2-DDAFA10980A6

P2860

Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children

Item

http://www.wikidata.org/entity/Q37513856

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of Lopinavir and Nevira ...... erienced HIV-infected Children

@en

Effect of Lopinavir and Nevira ...... rienced HIV-infected Children.

@nl

type

Item

label

Effect of Lopinavir and Nevira ...... erienced HIV-infected Children

@en

Effect of Lopinavir and Nevira ...... rienced HIV-infected Children.

@nl

prefLabel

Effect of Lopinavir and Nevira ...... erienced HIV-infected Children

@en

Effect of Lopinavir and Nevira ...... rienced HIV-infected Children.

@nl

P1476

Effect of Lopinavir and Nevira ...... erienced HIV-infected Children

@en

P2093

Faeezah Patel

http://www.w3.org/2001/XMLSchema#string

Francoise Pinillos

http://www.w3.org/2001/XMLSchema#string

Retsilisitsoe R Moholisa

http://www.w3.org/2001/XMLSchema#string

Sandra Castel

http://www.w3.org/2001/XMLSchema#string

P2860

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting.

The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.

Antiretroviral therapies in women after single-dose nevirapine exposure.

Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimen

Therapeutic drug monitoring in children with HIV/AIDS.

Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial

Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.

Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1-infected children and adolescents: an open-label, multiple-dose, cross-over study.

Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children.

P304

e378-e383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/INF.0000000000001319

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27583591

http://www.w3.org/2001/XMLSchema#string

P932

5166428

http://www.w3.org/2001/XMLSchema#string

Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children

about

P2860

P2860

Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932